27 results
CORRESP
CTKB
Cytek BioSciences Inc
2 Jul 21
Correspondence with SEC
12:00am
to be recorded in future periods will be classified as cost of sales,
Cooley LLP 3175 Hanover Street Palo Alto, CA 94304-1130
t: (650) 843-5000 f: (650 … includes $3.4 million of payment for instruments sold in past periods before the effective date of the BD Agreement in October 2020, classified
8-K/A
EX-99.2
CTKB
Cytek BioSciences Inc
15 May 23
Financial Statements and Exhibits
4:03pm
classified in Cost of Sales: Product, and $0.1 million classified in general and administrative expense.
The FCI business unit’s historical depreciation
UPLOAD
CTKB
Cytek BioSciences Inc
28 Jun 21
Letter from SEC
12:00am
to be recorded in future periods will be
classified as cost of sales,
how you accounted for the issuance of 1,565,698 shares of
common
10-K
2021 FY
EX-4.3
CTKB
Cytek BioSciences Inc
17 Mar 22
Annual report
4:38pm
that the authorized number of directors may be changed only by resolution of our board of directors;
provide that our board of directors is classified
DEF 14A
pxsog6 92480r
14 Apr 22
Definitive proxy
4:01pm
DRS
au61 kdtwp0sxsfc
22 Apr 21
Draft registration statement
12:00am
S-3ASR
x2upksfy8wsk
26 Aug 22
Automatic shelf registration
5:07pm
S-1/A
jo723s0tj651tb2
13 Jul 21
IPO registration (amended)
9:03pm
S-1
bi6d0y0ju1ycpm thcr
2 Jul 21
IPO registration
4:34pm
424B4
dspnd 3lm9bas7t13527
23 Jul 21
Prospectus supplement with pricing info
4:12pm
DRS/A
e3kbsx 0z814senc
14 Jun 21
Draft registration statement (amended)
12:00am